SFX-01 After Subarachnoid Haemorrhage

NCT02614742 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Subarachnoid Hemorrhage, Spontaneous

Interventions

DRUG: SFX-01
DRUG: Placebo

Sponsor

Evgen Pharma